IL27537A - Basically substituted oximes of 6,11-dihydrodibenzo-(b,e)-oxepinor-thiepin-11-ones and their production - Google Patents
Basically substituted oximes of 6,11-dihydrodibenzo-(b,e)-oxepinor-thiepin-11-ones and their productionInfo
- Publication number
- IL27537A IL27537A IL2753767A IL2753767A IL27537A IL 27537 A IL27537 A IL 27537A IL 2753767 A IL2753767 A IL 2753767A IL 2753767 A IL2753767 A IL 2753767A IL 27537 A IL27537 A IL 27537A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- reacting
- production
- salt
- basically substituted
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 150000002923 oximes Chemical class 0.000 title description 6
- 150000003839 salts Chemical class 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 3
- GAIRGASUWHLTOE-UHFFFAOYSA-N 3h-oxepin-2-one Chemical compound O=C1CC=CC=CO1 GAIRGASUWHLTOE-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- QGZKDVFQNNGYKY-AKLPVKDBSA-N Ammonia-N17 Chemical compound [17NH3] QGZKDVFQNNGYKY-AKLPVKDBSA-N 0.000 claims 1
- 241000282320 Panthera leo Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000009835 boiling Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- -1 magnesium halides Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/12—[b,e]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF0048699 | 1966-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL27537A true IL27537A (en) | 1970-11-30 |
Family
ID=7102426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2753767A IL27537A (en) | 1966-03-18 | 1967-03-06 | Basically substituted oximes of 6,11-dihydrodibenzo-(b,e)-oxepinor-thiepin-11-ones and their production |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE695653A (OSRAM) |
| CH (1) | CH488689A (OSRAM) |
| DE (1) | DE1543578C3 (OSRAM) |
| DK (1) | DK113021B (OSRAM) |
| ES (2) | ES338208A1 (OSRAM) |
| FR (2) | FR1514844A (OSRAM) |
| GB (1) | GB1123527A (OSRAM) |
| IL (1) | IL27537A (OSRAM) |
| NL (1) | NL6704075A (OSRAM) |
| SE (1) | SE327996B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4003915A (en) * | 1970-10-09 | 1977-01-18 | Hoffmann-La Roche Inc. | Tricyclic imines |
| EP4574870A1 (de) | 2023-12-19 | 2025-06-25 | Covestro Deutschland AG | Blockiertes polyisocyanat |
-
1966
- 1966-03-18 DE DE19661543578 patent/DE1543578C3/de not_active Expired
-
1967
- 1967-02-14 CH CH213167A patent/CH488689A/de not_active IP Right Cessation
- 1967-03-06 IL IL2753767A patent/IL27537A/en unknown
- 1967-03-17 NL NL6704075A patent/NL6704075A/xx unknown
- 1967-03-17 SE SE03758/67A patent/SE327996B/xx unknown
- 1967-03-17 BE BE695653D patent/BE695653A/xx unknown
- 1967-03-17 FR FR99337A patent/FR1514844A/fr not_active Expired
- 1967-03-17 DK DK142567A patent/DK113021B/da unknown
- 1967-03-18 ES ES338208A patent/ES338208A1/es not_active Expired
- 1967-03-20 GB GB12969/67A patent/GB1123527A/en not_active Expired
- 1967-04-27 ES ES339858A patent/ES339858A1/es not_active Expired
- 1967-06-16 FR FR110758A patent/FR6552M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE695653A (OSRAM) | 1967-09-18 |
| NL6704075A (OSRAM) | 1967-09-19 |
| DE1543578A1 (de) | 1969-09-18 |
| DE1543578C3 (de) | 1974-10-10 |
| DK113021B (da) | 1969-02-10 |
| ES338208A1 (es) | 1968-04-01 |
| SE327996B (OSRAM) | 1970-09-07 |
| FR6552M (OSRAM) | 1968-12-16 |
| ES339858A1 (es) | 1968-05-16 |
| GB1123527A (en) | 1968-08-14 |
| CH488689A (de) | 1970-04-15 |
| DE1543578B2 (de) | 1974-03-14 |
| FR1514844A (fr) | 1968-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5824698A (en) | Antibacterial dibenzimidazole derivatives | |
| WO2006018222A1 (de) | Hydrate und polymorphe des 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamid, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| SK287145B6 (sk) | Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie | |
| US3639477A (en) | Novel propoxyguanidine compounds and means of producing the same | |
| EP0047536A2 (en) | Substituted propylamines | |
| US4366166A (en) | Filaricidal 2-nitroimidazole compounds | |
| HU180430B (en) | Process for preparing substituted 2-phenyl-imino-imidazolidines and acid addition salts thereof infulencing the cardiovascular system | |
| CA2164296C (en) | Heterocyclic chemistry | |
| IL27537A (en) | Basically substituted oximes of 6,11-dihydrodibenzo-(b,e)-oxepinor-thiepin-11-ones and their production | |
| US3179665A (en) | 9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes | |
| US3505404A (en) | 3,3-dialkyl-1-phenyl-1-indanalkylamines | |
| IL50304A (en) | 2-(4-methyl-1-piperazinyl)-4-tert butylthiazole its preparation and pharmaceutical compositions containing it | |
| US3929833A (en) | Organic compounds | |
| US20030069417A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| US4015002A (en) | 1-Aryl-2-oxo-2,4,5,6,7,7a-hexahydro-indoles, salts, pharmaceutical compositions and methods of use | |
| HU184791B (en) | Process for preparing derivatives of tetrahydro-pyrid-4-yl-indole | |
| US3313687A (en) | Appetite-suppressing and weight reducing composition | |
| DE3423003A1 (de) | Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| US3576811A (en) | 1-alkyl-1-(beta-piperidino-ethyl)-1,2,3,4- tetrahydronaphthalen-2-ones | |
| HU178272B (en) | Process for preparing new piperazino-methane-imino derivatives | |
| US3377245A (en) | Methods and compositions for treating hypertension | |
| US3812135A (en) | Pyrroloindole and pyridoindole derivatives | |
| US3294638A (en) | Method and compositions employing 2-alkyl-3-piperidinopyrazines | |
| EP0001266B1 (en) | Substituted 2-aminomethylphenyl sulfamates, process for preparing, and pharmaceutical compositions containing the same | |
| US3574752A (en) | 5-(2-alkylaminoethylidene)-10,11-dihydro-and-5h-dibenzo(a,d)cycloheptenes and the salts thereof |